Aplastic anemia as a feature of systemic lupus erythematosus: A case report and literature review

Rheumatology International

Volumn 35, Issue 6, 2015, Pages 1073-1082

  Chalayer, Émilie ^a   Ffrench, Martine ^b   Cathébras, Pascal ^a  

^a HÔPITAL NORD   (France)

^b CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

Aplastic anemia; Bone marrow; Systemic lupus erythematosus

Indexed keywords

CORTICOSTEROID; CORTISONE; CYCLOSPORIN; HYDROXYCHLOROQUINE; IMMUNOMODULATING AGENT; METHYLPREDNISOLONE; MYCOPHENOLATE MOFETIL; PREDNISONE; THYMOCYTE ANTIBODY; IMMUNOSUPPRESSIVE AGENT;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; APLASTIC ANEMIA; BONE MARROW BIOPSY; CELL DESTRUCTION; CORTICOSTEROID THERAPY; CYTOPENIA; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG WITHDRAWAL; HEMATOPOIETIC STEM CELL; MORTALITY; NEPHROTIC SYNDROME; PANCYTOPENIA; PATHOPHYSIOLOGY; PLASMAPHERESIS; PRIORITY JOURNAL; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME; TREATMENT RESPONSE; ANEMIA, APLASTIC; BIOPSY; BONE MARROW EXAMINATION; CASE REPORT; COMPLICATION; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOLOGY; LUPUS ERYTHEMATOSUS, SYSTEMIC; PREDICTIVE VALUE; RISK FACTOR; YOUNG ADULT;

ANEMIA, APLASTIC; BIOPSY; BONE MARROW EXAMINATION; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PREDICTIVE VALUE OF TESTS; RISK FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84938250002     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-014-3162-4     Document Type: Review

References (33)

1. Hepburn AL, Narat S, Mason JC (2010) The management of peripheral blood cytopenias in systemic lupus erythematosus. Rheumatol 49:2243–2254. doi:10.1093/rheumatology/keq269
2. Beyan E, Beyan C, Turan M (2007) Hematological presentation in systemic lupus erythematosus and its relationship with disease activity. Hematology 12:257–261. doi:10.1080/10245330701214145
3. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725–1734. doi:10.1002/1529-0131(199709)40:9<1725:AID-ART29>3.0.CO;2-Y
4. Young NS, Scheinberg P, Calado RT (2008) Aplastic anemia. Curr Opin Hematol 15:162–168. doi:10.1097/MOH.0b013e3282fa7470
5. Young NS, Bacigalupo A, Marsh JCW (2010) Aplastic anemia: pathophysiology and treatment. Biol Blood Marrow Transplant 16:S119–S125. doi:10.1016/j.bbmt.2009.09.013
6. Alishiri GH, Saburi A, Bayat N et al (2012) The initial presentation of systemic lupus erythematosis with aplastic anemia successfully treated with rituximab. Clin Rheumatol 31(2):381–384
7. Hinterberger-Fischer M, Höcker P, Lechner K et al (1989) Oral cyclosporin-A is effective treatment for untreated and also for previously immunosuppressed patients with severe bone marrow failure*. Eur J Haematol 43:136–142
8. Fitchen JJ, Cline MJ, Saxon A, Golde DW (1979) Serum inhibitors of hematopoiesis in a patient with aplastic anemia and systemic lupus erythematosus: recovery after exchange plasmapheresis. Am J Med 66:537–542
9. Ahmad SQ, Khan O, Zafar SI, Zafar SN (2011) A case of systemic lupus erythematosus with aplastic anaemia. J Pak Med Assoc 61:817–819
10. Baumann P, Völkl A, Bäuerle M et al (2011) Aplastic crisis as primary manifestation of systemic lupus erythematosus. Onkologie 34:452–454. doi:10.1159/000331069
11. Seo S-R, Lee S-J, Park D-J et al (2011) Successful treatment using cyclosporine in a patient with rhupus complicated by aplastic anemia: a case report and review of the literature. Clin Exp Rheumatol 29:708–711
12. Singh NP, Prakash A, Garg D et al (2004) Aplastic anemia complicating systemic lupus erythematosus: successful management with cyclosporine. Rheumatol Int 24:40–42
13. Tabushi Y, Fukazawa T, Abe K et al (2003) A case of aplastic anemia in a patient with systemic lupus erythematosus. Mod Rheumatol 13:177–180
14. Pavithran K, Raji N, Thomas M (2002) Aplastic anemia complicating systemic lupus erythematosus-report of a case and review of the literature. Rheumatol Int 22:253–255
15. Tagoe C, Shah A, Yee H, Belmont HM (2001) Aplastic anemia in systemic lupus erythematosus: a distinct presentation of acquired aplastic anemia? J Clin Rheumatol 7:377–383
16. Morishita Y, Matsukawa Y, Kura Y et al (1997) Antithymocyte globulin for a patient with systemic lupus erythematosus complicated by severe pancytopenia. J Int Med Res 25:219–223
17. Chute JP, Hoffmeister K, Cotelingam J et al (1996) Aplastic anemia as the sole presentation of systemic lupus erythematosus. Am J Hematol 51:237–239. doi:10.1002/(SICI)1096-8652(199603)51:3<237:AID-AJH10>3.0.CO;2-D
18. Marqués JA, Rhim H, Distenfeld A (1995) Inhibition of hematopoiesis by a plasma factor in a case of aplastic anemia associated with systemic lupus erythematosus. P R Health Sci J 14:293–296
19. Meyerson MA, Cohen PR (1994) Dapsone-induced aplastic anemia in a woman with bullous systemic lupus erythematosus. Mayo Clin Proc 69:1159–1162
20. Sumimoto SI, Kawai M, Kasajima Y, Hamamoto T (1991) Aplastic anemia associated with systemic lupus erythematosus. Am J Hematol 38:329–331
21. Roffe C, Cahill MR, Samanta A et al (1991) Aplastic anaemia in systemic lupus erythematosus: a cellular immune mechanism? Br J Rheumatol 30:301–304
22. Bailey FA, Lilly M, Bertoli LF, Ball GV (1989) An antibody that inhibits in vitro bone marrow proliferation in a patient with systemic lupus erythematosus and aplastic anemia. Arthritis Rheum 32:901–905
23. Winkler A, Jackson RW, Kay DS et al (1988) High-dose intravenous cyclophosphamide treatment of systemic lupus erythematosus-associated aplastic anemia. Arthritis Rheum 31:693–694
24. Saal JG, Daniel PT, Berg PA, Waller HD (1985) Indoprofen-induced aplastic anaemia in systemic lupus, diagnosed by lymphocyte transformation tests. Lancet 1:1450–1451
25. Stricker RB, Shuman MA (1984) Aplastic anemia complicating systemic lupus erythematosus: response to androgens in two patients. Am J Hematol 17:193–201
26. Brooks BJ Jr, Broxmeyer HE, Bryan CF, Leech SH (1984) Serum inhibitor in systemic lupus erythematosus associated with aplastic anemia. Arch Int Med 144:1474
27. Walport MJ, Hubbard WN, Hughes GRV (1982) Reversal of aplastic anaemia secondary to systemic lupus erythematosus by high-dose intravenous cyclophosphamide. Br Med J (Clin Res Ed) 285:769
28. Chalayer E, Stagnara J, Ffrench M, Cathébras P (2014) Bone marrow fibrosis as a feature of systemic lupus erythematosus: a case report and literature review. Springerplus 3:349
29. Hepburn AL, Lampert IA, Boyle JJ et al (2007) In vivo evidence for apoptosis in the bone marrow in systemic lupus erythematosus. Ann Rheum Dis 66:1106–1109. doi:10.1136/ard.2006.065003
30. Pullarkat V, Bass RD, Gong JZ et al (2003) Primary autoimmune myelofibrosis: definition of a distinct clinicopathologic syndrome. Am J Hematol 72:8–12. doi:10.1002/ajh.10258
31. Bass RD, Pullarkat V, Feinstein DI et al (2001) Pathology of autoimmune myelofibrosis a report of three cases and a review of the literature. Am J Clin Pathol 116:211–216
32. Young NS, Gerson SL, High KA (2006) Clinical hematology. Mosby/Elsevier, Philadelphia, Pennsylvania, pp 887–899
33. Scheinberg P (2012) Aplastic anemia: therapeutic updates in immunosuppression and transplantation. Hematol Am Soc Hematol Educ Program 2012:292–300. doi:10.1182/asheducation-2012.1.292